Multicenter phase II feasibility trial of high-dose tamoxifen in patients with refractory or relapsed multiple myeloma. [electronic resource]
Producer: 20040505Description: 636-7 p. digitalISSN:- 1460-2105
- Antineoplastic Agents, Hormonal -- administration & dosage
- Chromatography, High Pressure Liquid
- Drug Administration Schedule
- Estrogen Receptor Modulators -- administration & dosage
- Feasibility Studies
- Humans
- Multiple Myeloma -- drug therapy
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Tamoxifen -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.